The role of the Xpert MTB/RIF assay among adolescents suspected of pulmonary tuberculosis in Rio de Janeiro, Brazil
Rev. Soc. Bras. Med. Trop
;
51(2): 234-236, Mar.-Apr. 2018. graf
Article
Dans Anglais
| LILACS
| ID: biblio-1041454
ABSTRACT
Abstract INTRODUCTION The teste rápido molecular para tuberculose (TRM-TB) was introduced in 2014 in Brazil for tuberculosis screening. However, its role in adolescents in Brazil has not been studied. METHODS A descriptive study of adolescents with suspected tuberculosis using National Laboratory software. RESULTS Of 852 (15.4%) suspected cases, 131 were positive by TRM-TB and 2% were resistant to rifampicin. Among TRM-TB-positive cases, 105 (91.4%) were culture-positive. Sixty-four of 96 samples were sensitive to rifampicin by TRM-TB; 11 were resistant to other drugs by drug sensitivity test (DST). CONCLUSIONS Among suspected cases, 16% were diagnosed by TRM-TB, of which 17% were drug-resistant by DST.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Rifampicine
/
Streptomycine
/
Tuberculose multirésistante
/
Isoniazide
/
Antibiotiques antituberculeux
/
Mycobacterium tuberculosis
Type d'étude:
Étude observationnelle
/
Étude de prévalence
/
Facteurs de risque
Limites du sujet:
Adolescent
/
Enfant
/
Humains
Pays comme sujet:
Amérique du Sud
/
Brésil
langue:
Anglais
Texte intégral:
Rev. Soc. Bras. Med. Trop
Thème du journal:
Médecine tropicale
Année:
2018
Type:
Article
Pays d'affiliation:
Brésil
/
États-Unis d'Amérique
Institution/Pays d'affiliation:
Alpert Medical School of Brown University/US
/
Secretaria Municipal de Saúde de Nova Iguaçu/BR
/
Secretaria Municipal de Saúde do Rio de Janeiro/BR
/
Universidade Federal do Rio de Janeiro/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS